Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Handbook of Experimental Pharmacology|March 6, 2010
Species differences in pharmacokinetics and pharmacodynamicsPierre-Louis Toutain, Aude Ferran, Alain Bousquet-Mélou
The Journal of Antimicrobial Chemotherapy|October 13, 2007
AUC/MIC: a PK/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor?Pierre-Louis Toutain, Alain Bousquet-Mélou, Marilyn Martinez
Veterinary Microbiology|October 5, 2010
Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infectionAude A Ferran, Pierre-Louis Toutain, Alain Bousquet-Mélou
Antimicrobial Agents and Chemotherapy|August 22, 2007
Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacinAude Ferran, Véronique Dupouy, Pierre-Louis Toutain, et al.
International Journal for Parasitology|October 20, 2004
Endectocide exchanges between grazing cattle after pour-on administration of doramectin, ivermectin and moxidectinAlain Bousquet-Mélou, Sonia Mercadier, Michel Alvinerie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Intestinal secretion is a major route for parent ivermectin elimination in the ratCéline M Laffont, Pierre-Louis Toutain, Michel Alvinerie, et al.
Frontiers in Microbiology|August 18, 2016
Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus BiofilmsAude A Ferran, JingJing Liu, Pierre-Louis Toutain, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2009
Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection modelAude A Ferran, Anne-Sylvie Kesteman, Pierre-Louis Toutain, et al.
Frontiers in Veterinary Science|September 14, 2017
Implementing Precision Antimicrobial Therapy for the Treatment of Bovine Respiratory Disease: Current Limitations and PerspectivesGuillaume Lhermie, Pierre-Louis Toutain, Farid El Garch, et al.
Frontiers in Microbiology|June 16, 2022
Repeated Exposure of Escherichia coli to High Ciprofloxacin Concentrations Selects gyrB Mutants That Show Fluoroquinolone-Specific HyperpersistenceAurore Perault, Catherine Turlan, Nathalie Eynard, et al.
Pageof 5